Follow
NNV Radharani
NNV Radharani
Postdoc at Department of Laboratory Medicine, BMC, Lund University, Sweden
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Osteopontin as a therapeutic target for cancer
M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ...
Expert opinion on therapeutic targets 18 (8), 883-895, 2014
1442014
RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer
AS Yadav, NNV Radharani, M Gorain, A Bulbule, D Shetti, G Roy, T Baby, ...
Nanoscale 12 (19), 10664-10684, 2020
772020
Notch1-MAPK signaling axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis
D Kumar, S Kumar, M Gorain, D Tomar, HS Patil, NNV Radharani, ...
Journal of Investigative Dermatology 136 (12), 2462-2474, 2016
752016
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway
NNV Radharani, AS Yadav, R Nimma, TVS Kumar, A Bulbule, ...
Cancer cell international 22 (1), 122, 2022
602022
The biology and therapeutic implications of tumor dormancy and reactivation
AS Yadav, PR Pandey, R Butti, NNV Radharani, S Roy, SR Bhalara, ...
Frontiers in oncology 8, 72, 2018
572018
Ultrahigh penetration and retention of graphene quantum dot mesoporous silica nanohybrids for image guided tumor regression
R Prasad, NK Jain, AS Yadav, M Jadhav, NNV Radharani, M Gorain, ...
ACS Applied Bio Materials 4 (2), 1693-1703, 2021
162021
Role of osteopontin in tumor microenvironment: a new paradigm in cancer therapy
R Butti, P Ghosh, KVS Totakura, RNN Venkata, R Nimma, GC Kundu
Multi-targeted approach to treatment of cancer, 113-125, 2015
112015
pH-responsive nanomedicine for breast cancer targeting
AS Yadav, IG Kundu, NNV Radharani, B Mishra, GC Kundu
Targeted Nanomedicine for Breast Cancer Therapy, 335-349, 2022
12022
SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions
I Kundu, NNV Radharani, AS Yadav, S Patnaik, GC Kundu
Coronaviruses 2 (7), 9-21, 2021
12021
Oxidative stress: a key regulator of Breast cancer progression and drug resistance
NNV Radharani, IG Kundu, AS Yadav, GC Kundu
Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 1-15, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–10